Physician

Fernando Jose Colato Zavaleta

According to 2025 Medicare claims, Fernando Zavaleta (NPI: 1669630737) practices cardiology in the College Station-Bryan, TX market, with the plurality of this provider's patient population coming from Brazos, TX. This provider's primary affiliated billing organization is CENTRAL TEXAS HEART CENTER (NPI: 1871666271; TIN: 742542858) and primary practice location at 77802-2586. Zavaleta is affiliated with the CommonSpirit ACO I (ACO ID: A2164) and Baylor Scott & White Quality Alliance (ACO ID: A2542), participating under the MSSP model.

Zavaleta's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 960 traditional Medicare patients, billed 9,531 HCPCS/CPT codes, and received $764,996 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 7,867 prescription claims across 903 beneficiaries totaling $1,623,453 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 14 claims. Open Payments data shows 56 records totaling $1,068. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $326,620 to $764,996. Similarly, Part D prescription costs have moved sharply higher in recent years, from $59,167 to $1,623,453. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $86,013 to $35,109.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	716	5,342	$326,620
2016	918	7,834	$475,994
2017	1,040	9,555	$702,206
2018	1,127	8,864	$834,081
2019	1,177	7,441	$834,560
2020	961	5,679	$710,009
2021	1,019	7,252	$873,718
2022	1,014	5,578	$737,504
2023	1,083	9,659	$904,150
2024	960	9,531	$764,996

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	156	1,178	$59,167
2016	250	1,918	$109,637
2017	375	3,188	$224,411
2018	465	4,321	$402,187
2019	570	5,815	$681,883
2020	641	6,722	$932,159
2021	695	6,699	$1,084,133
2022	716	6,841	$1,207,924
2023	815	7,584	$1,525,988
2024	903	7,867	$1,623,453

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	16	42	$86,013
2016	12	25	$50,201
2017	N/R	20	$41,211
2018	13	42	$84,296
2019	16	50	$102,714
2020	N/R	13	$27,018
2021	N/R	14	$29,901
2022	N/R	N/R	N/R
2023	N/R	14	$33,476
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	206	267	$128
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	736	818	$110
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	503	713	$86
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	152	152	$52
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	378	415	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	644	33,131	$618,528
Entresto	Sacubitril/Valsartan	334	17,717	$362,156
Repatha Sureclick	Evolocumab	251	10,560	$198,178
Jardiance	Empagliflozin	94	4,968	$94,669
Xarelto	Rivaroxaban	73	4,290	$77,215

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	56	$1,068	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Fernando Jose Colato Zavaleta?

Tedicare shows public-source Medicare data for Fernando Jose Colato Zavaleta (NPI 1669630737), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Fernando Jose Colato Zavaleta have ACO affiliation data?

Fernando Jose Colato Zavaleta is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164) and Baylor Scott & White Quality Alliance (MSSP, ACO ID A2542).

What billing organization is linked to Fernando Jose Colato Zavaleta?

Fernando Jose Colato Zavaleta is linked to CENTRAL TEXAS HEART CENTER (billing NPI 1871666271) in the available physician profile data.

Does Fernando Jose Colato Zavaleta have Open Payments data?

Fernando Jose Colato Zavaleta has 56 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.